ABIOMED, Inc. - Common Stock (NQ:ABMD)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Dec 21, 2022 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ABIOMED, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Beat the Dow Jones With This Unstoppable Dividend Stock ↗

November 05, 2022

Johnson & Johnson has outperformed the Dow so far this year.

Via The Motley Fool

Stock Market Rally Tumbles On Hawkish Fed Chief Powell; Jobs, Earnings Also In Focus: Weekly Review ↗

November 04, 2022

A mixed jobs report and heavy earnings swung stocks.

Via Investor's Business Daily

Here's How Much $100 Invested In Abiomed 20 Years Ago Would Be Worth Today ↗

November 04, 2022

Abiomed (NASDAQ:ABMD) has outperformed the market over the past 20 years by 18.13% on an annualized basis producing an average annual return of 25.63%. Currently, Abiomed has a market capitalization of...

Via Benzinga

5 Analysts Have This to Say About Abiomed ↗

November 02, 2022

Over the past 3 months, 5 analysts have published their opinion on Abiomed (NASDAQ:ABMD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022 ↗

November 02, 2022

Upgrades

Via Benzinga

Is Johnson & Johnson an Underrated Growth Stock? ↗

November 02, 2022

Johnson & Johnson trades at a modest earnings multiple, and it may warrant a premium.

Via The Motley Fool

Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday ↗

November 02, 2022

Gainers

Via Benzinga

Gartner, Sony, Uber And Other Big Gainers From Tuesday ↗

November 02, 2022

U.S. stocks closed lower on Tuesday, with the Nasdaq Composite dropping around 100 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

ABIOMED INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Abiomed, Inc. - ABMD

November 01, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

Why Abiomed Stock Skyrocketed Today ↗

November 01, 2022

A healthcare titan wants to acquire the medical technology specialist for a whopping $16.6 billion.

Via The Motley Fool

What To Watch In The S&P Biotech ETF After Johnson & Johnson's $16.6B Abiomed Deal ↗

November 01, 2022

As the exodus out of mega-cap technology stocks continues, investors and money managers are looking for other sectors to rotate into.

Via Benzinga

10 Best Stocks to Buy Now in November ↗

November 01, 2022

These beaten-down growth stocks have significant upside.

Via The Motley Fool

Nasdaq Down 60 Points; Eli Lilly Lowers Earnings Forecast ↗

November 01, 2022

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 70 points on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 01, 2022

Gainers

Via Benzinga

Investors Wary Of Potential Fed Response To Resilient Labor Market ↗

November 01, 2022

Stocks are pulling back from their morning gains, following data that showed U.S. job openings rose to 10.7 million in September.

Via Talk Markets

Johnson & Johnson (NYSE: JNJ) Set to Acquire Abiomed (NASDAQ: ABMD) for $16.6 Billion or $380 per Share Plus CVR

November 01, 2022

Abiomed, Inc. (NASDAQ: ABMD) is engaged as a medical technology company, which is focused on providing support and resources to

Via Spotlight Growth

Dow Drops Over 200 Points; Crude Oil Rises Sharply ↗

November 01, 2022

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Tuesday.

Via Benzinga

Why Is Uber Stock Up Today? ↗

November 01, 2022

Uber (UBER) stock is on the move Tuesday as investors react to results from the company's earnings report for the third quarter of 2022.

Via InvestorPlace

Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session ↗

November 01, 2022

Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads.

Via Benzinga

US Stocks Trade Lower Ahead Of Fed Meeting; Pfizer Earnings Top Views ↗

November 01, 2022

U.S. stocks traded lower this morning, with the Dow Jones dropping around 80 points on Tuesday.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022 ↗

November 01, 2022

Upgrades

Via Benzinga

Why Is Carvana (CVNA) Stock Up 15% Today? ↗

November 01, 2022

Carvana (CVNA) stock is climbing higher on Tuesday after JPMorgan analyst Rajat Gupta upgraded the company's shares to neutral.

Via InvestorPlace

Why Is Abiomed (ABMD) Stock Up 50% Today? ↗

November 01, 2022

Abiomed will become part of Johnson & Johnson's huge medical devices unit after being bought for $16.6 billion in cash.

Via InvestorPlace

Johnson & Johnson Expands Cardiovascular Portfolio, Bets $16B In Abiomed's Heart Failure Devices ↗

November 01, 2022

Via Benzinga

Uber Rides Higher, but Here's Tuesday's Big Stock Winner ↗

November 01, 2022

Earnings are only part of the story.

Via The Motley Fool

Recap: Abiomed Q2 Earnings ↗

November 01, 2022

Abiomed (NASDAQ:ABMD) reported its Q2 earnings results on Tuesday, November 1, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Abiomed beat estimated earnings by...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

November 01, 2022

Good morning, investor! It's time to start the day with a breakdown of the biggest pre-market stock movers for Tuesday morning!

Via InvestorPlace

ABMD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of ABIOMED, Inc. Is Fair to Shareholders

November 01, 2022

From Halper Sadeh LLC

Via Business Wire

Abiomed Announces Second Quarter Revenue of $266 Million, up 11% in Constant Currency*, up 7% on a Reported Basis Year Over Year

November 01, 2022

From Abiomed, Inc.

Via Business Wire

Johnson & Johnson to Acquire Abiomed

November 01, 2022

From Johnson & Johnson

Via Business Wire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.